Cited 9 times in
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.